Multiplex Cancer Diagnostics for Precise & Personalized Treatment.

Revolutionizing Diagnostics with Patented Nanobead Technology for High-Precision Multiplex Biomarker Detection. 
Discover more
Vega Bioimaging
Vega Bioimaging precision and accuracy

Superior Precision and Accuracy for Cancer Subtyping and Treatment Response Prediction

Vega BioImaging is a precision medicine company at the forefront of innovation in cancer diagnostics thanks to their patented nanotechnology. Our advanced diagnostic kits provide quantitative, multiplexed biomarker detection, overcoming the limitations of traditional immunohistochemistry (IHC) by providing enhanced sensitivity, stability, and accuracy in cancer subtyping and treatment response prediction.

Empowering Pathologists with Next-Generation Imaging Solutions

Group 25

Our platform combines:

  • Innovative use of functionalized nanobeads
  • Advanced optical microscopy
  • Sophisticated AI algorithms

To provide:

Quantitative, multiplexed, and highly sensitive detection of cancer biomarkers.

Vega Bioimaging
1.

Precision and Accuracy

Our diagnostic kits provide unprecedented sensitivity and quantitative multiplexing, enabling precise detection of cancer biomarkers. This results in more accurate diagnoses and personalized treatment strategies.

2.

Time Efficiency

Our technology reduces diagnostic delays by enabling simultaneous detection of multiple biomarkers in the same biopsy sample, speeding up treatment decisions and improving patient outcomes.

3.

Cost-Effective Solutions

By reducing the need for multiple tests and minimizing diagnostic errors, Vega BioImaging helps lower healthcare costs while improving treatment efficacy.

4.

Better Treatment Predictions

With enhanced ability to predict treatment responses, our diagnostic kits offer physicians deeper insights into cancer subtypes, allowing for more effective and personalized therapies.

5.

Support for Drug Development

Vega BioImaging collaborates with pharmaceutical companies to develop companion diagnostics (CDx), optimizing drug development by identifying patient populations most likely to benefit from new therapies.

Learn more
Why Vega Bioimaging

Why Vega BioImaging ?

Why Vega Bioimaging
Vega BioImaging is a precision medicine company at the forefront of innovation in cancer diagnostics thanks to our patented nanotechnology. Our advanced diagnostic kits provide quantitative, multiplexed biomarker detection, overcoming the limitations of traditional immunohistochemistry (IHC) by providing enhanced sensitivity, stability, and accuracy in cancer subtyping and treatment response prediction.
Learn more about VEGA

Innovative Nanotechnology

Unlike traditional IHC and immunofluorescence, our patented nanobeads provide quantitative, multiplexed detection with higher stability and sensitivity, setting a new standard for cancer diagnostics.

AI Integration

Our advanced AI algorithms enhance the analysis of complex data sets, ensuring more accurate diagnostic interpretations and faster decision-making.

Highly Scalable

Vega BioImaging’s solutions are easily scalable, with a focus on reducing costs for pharmaceutical companies and healthcare systems through enhanced companion diagnostics.